RA
NCIT

Royce & Associates’s NCI, Inc. NCIT Stock Holding History

Royce & Associates’s Portfolio NCIT Stock Details NCIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-677,231
Closed -$14.3M – 1287
2017
Q2 		$14.3M Buy
677,231
+168,089
+33% +$2.89M 0.09% 298
2017
Q1 		$7.66M Buy
+509,142
New +$7.15M 0.05% 461
2014
Q1 		– Sell
-30,000
Closed -$199K – 1481
2013
Q4 		$199K Buy
30,000
+7,532
+34% +$44.8K ﹤0.01% 1306
2013
Q3 		$126K Buy
+22,468
New +$115K ﹤0.01% 1334

Royce & Associates's NCIT Position: Q3 2017 in Review

Royce & Associates sold out of NCI, Inc. (NCIT) in Q3 2017, closing a stake of 677,231 shares — an estimated $14.3M sold.

Royce & Associates first reported a position in NCIT in Q3 2013 and held it in 4 quarters. The position peaked at $14.3M in Q2 2017. 0 funds tracked by Wall St. Rank hold NCIT as of Q3 2017.

  • Royce & Associates reported no remaining NCI, Inc. position as of Q3 2017 after selling out during the quarter.
  • Royce & Associates sold 677,231 NCI, Inc. shares in Q3 2017, an estimated $14.3M.
  • Royce & Associates first reported a position in NCI, Inc. in Q3 2013 and held it in 4 quarters.
  • Royce & Associates's NCI, Inc. position peaked at $14.3M in Q2 2017.
  • 0 funds tracked by Wall St. Rank held NCI, Inc. as of Q3 2017.

Based on Royce & Associates's 13F filing for Q3 2017, filed 13 Nov 2017.